Literature DB >> 6645304

[Kidney involvement in liver diseases. Pathophysiology and clinical course].

P Schmidt.   

Abstract

Renal disorders complicating liver disease are a frequent finding. Extrahepatic causes like intoxications and circulatory dysfunction or diseases that simultaneously affect both the liver and the kidney, like multisystem or viral diseases (hepatitis B) have to be differentiated from clinical entities in which, like in liver cirrhosis or in fulminant hepatitis, the manifestation of renal disease has to be understood as a consequence of the hepatic disorders. Functional disturbances like the increases in tubular sodium reabsorption or the hepatorenal syndrome have been thoroughly investigate because of their clinical importance. Substantial research dealing with the consequences of the increased intrahepatic vascular resistance on systemic and renal hemodynamics and with vasoactive substances, either arising from the liver or accumulating due to poor inactivation by the liver, have led - in the last years - to a better understanding of the pathophysiology of renal involvement in liver disease. However, the exact pathophysiologic role of factors like the effective blood volume, the sympathoadrenergic tonus, the activation of the renin-angiotensin-aldosterone system, changes of kinin activity or in prostaglandin release and the accumulation of "false" neurotransmitters and endotoxins still remains to be established.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6645304     DOI: 10.1007/BF01537502

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  39 in total

1.  The role of the kidney in Laennec's cirrhosis of the liver.

Authors:  S PAPPER
Journal:  Medicine (Baltimore)       Date:  1958-12       Impact factor: 1.889

2.  Aldosterone excretion in patients with cirrhosis of the liver.

Authors:  I DYRENFURTH; C H STACEY; J C BECK; E H VENNING
Journal:  Metabolism       Date:  1957-11       Impact factor: 8.694

3.  Glomerular changes in patients with cirrhosis of the liver.

Authors:  J Berger; H Yaneva; B Nabarra
Journal:  Adv Nephrol Necker Hosp       Date:  1977

4.  Renal morphological and immunological changes associated with acute viral hepatitis.

Authors:  G Eknoyan; F Györkey; C Dichoso; M Martinez-Maldonado; W N Suki; P Györkey
Journal:  Kidney Int       Date:  1972-06       Impact factor: 10.612

5.  Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

Authors:  S P Wilkinson; V Arroyo; B G Gazzard; H Moodie; R Williams
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

6.  Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.

Authors:  M H Koppel; J W Coburn; M M Mims; H Goldstein; J D Boyle; M E Rubini
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

7.  Secretion and turnover of aldosterone in various pathological states.

Authors:  P Vecsei; G Düsterdieck; J Jahnecke; D Lommer; H P Wolff
Journal:  Clin Sci       Date:  1969-04       Impact factor: 6.124

8.  The 'hepatorenal' syndrome and refractory ascites. Successful therapy with the LeVeen-type peritoneal-venous shunt and valve.

Authors:  M J Kinney; A Schneider; S Wapnick; S Grosberg; H LeVeen
Journal:  Nephron       Date:  1979       Impact factor: 2.847

9.  Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.

Authors:  R D Zipser; J C Hoefs; P F Speckart; P K Zia; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

10.  [Angiographic studies of kidney failure in endotoxinemia].

Authors:  J Wolter; G Viehweger; M Grün; H Liehr
Journal:  Chir Forum Exp Klin Forsch       Date:  1977-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.